Trust Company of Vermont’s Repligen RGEN Stock Holding History

Trust Company of Vermont’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$81.9K	Hold	500	–	–	﹤0.01%	482
2025 Q3	$66.8K	Buy	+500	New	+$60.7K	﹤0.01%	516

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Trust Company of Vermont's RGEN Position: Q4 2025 in Review

Trust Company of Vermont held its Repligen (RGEN) position steady in Q4 2025 at 500 shares worth $81.9K. The position accounts for ﹤0.01% of the portfolio, ranked #482.

Trust Company of Vermont first reported a position in RGEN in Q3 2025 and has held it in 2 quarters since. 474 funds tracked by Wall St. Rank hold RGEN as of Q4 2025.

Trust Company of Vermont held 500 shares of Repligen worth $81.9K as of Q4 2025.
Trust Company of Vermont left its Repligen share count unchanged in Q4 2025.
Repligen made up ﹤0.01% of Trust Company of Vermont's portfolio in Q4 2025, its #482 holding.
Trust Company of Vermont first reported a position in Repligen in Q3 2025 and has held it in 2 quarters since.
474 funds tracked by Wall St. Rank held Repligen as of Q4 2025.

Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.